A Trial of Varenicline for E-cigarette Cessation

NCT07040566 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

326

Enrollment

OTHER

Sponsor class

Conditions

E-cigarette Use
Vaping
Nicotine Dependence

Interventions

DRUG: Varenicline 1mg BID
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]